Evidence map›Paper›PMID 10594021›Full record

ArticleMolecular and cellular biology2000

The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression.

Y K Lee, H Dell, D H Dowhan, M Hadzopoulou-Cladaras, D D Moore

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 315 citations in OpenAlex.

  1. Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Drug metabolism and disposition: the biological fate of chemicals · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. The role of the retinoid receptor, RAR/RXR heterodimer, in liver physiology.Biochimica et biophysica acta. Molecular basis of disease · 2021
    Review
  11. Frontiers in pharmacology · 2021
    Article
  12. Research on the circadian clock gene HNF4a in different malignant tumors.International journal of medical sciences · 2021
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Y K LeeDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
H Dell
D H Dowhan
M Hadzopoulou-Cladaras
D D Moore
Baylor College of Medicine · USBoston University · US

Funding

Metabolic Regulation by the Nuclear Receptor CARR01DK046546 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MOORE, DAVID D · 1995 to 2014
$4.9M
HNF-4 AND APOLIPOPROTEIN B GENE EXPRESSIONR01HL056104 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HADZOPOULOU-CLADARAS, MARGARIT H · 1997 to 1999
–
NHLBI NIH HHS HL-56104NIDDK NIH HHS DK-46546NIDDK NIH HHS R01 DK046546
6 · The paper itself

Abstract

The orphan nuclear hormone receptor SHP interacts with a number of other nuclear hormone receptors and inhibits their transcriptional activity. Several mechanisms have been suggested to account for this inhibition. Here we show that SHP inhibits transactivation by the orphan receptor hepatocyte nuclear factor 4 (HNF-4) and the retinoid X receptor (RXR) by at least two mechanisms. SHP interacts with the same HNF-4 surface recognized by transcriptional coactivators and competes with them for binding in vivo. The minimal SHP sequences previously found to be required for interaction with other receptors are sufficient for interaction with HNF-4, although deletion results indicate that additional C-terminal sequences are necessary for full binding and coactivator competition. These additional sequences include those associated with direct transcriptional repressor activity of SHP. SHP also competes with coactivators for binding to ligand-activated RXR, and based on the ligand-dependent interaction with other nuclear receptors, it is likely that coactivator competition is a general feature of SHP-mediated repression. The minimal receptor interaction domain of SHP is sufficient for full interaction with RXR, as previously described. This domain is also sufficient for full coactivator competition. Functionally, however, full inhibition of RXR transactivation requires the presence of the C-terminal repressor domain, with only weak inhibition associated with this receptor interaction domain. Overall, these results suggest that SHP represses nuclear hormone receptor-mediated transactivation via two separate steps: first by competition with coactivators and then by direct effects of its transcriptional repressor function.

Indexed as

DNA-Binding ProteinsTranscriptional ActivationBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGene Expression RegulationHepatocyte Nuclear Factor 4HumansLiverPhosphoproteinsReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoid X ReceptorsSignal TransductionTranscription FactorsTumor Cells, CulturedBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsDNA-Binding ProteinsHepatocyte Nuclear Factor 4MLX protein, humannuclear receptor subfamily 0, group B, member 2PhosphoproteinsReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoid X ReceptorsTranscription Factors

Identifiers

PMID10594021
PMCPMC85074
OpenAlexW2134282794

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.